TAREG Safety Questions, TAREG Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TAREG. Our extensive database of TAREG adverse events and TAREG warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TAREG
TAREG Safety Reports
Total TAREG reports: 50.TAREG FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 27.
Take TAREG Side Effects Survey or Share Your TAREG Story. Read More Here.
Physician from FRANCE reported TAREG problem on Jan 02, 2007. Female patient was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: livedo reticularis. TAREG dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on Jan 24, 2007. Female patient, 62 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: activated protein c resistance, compression stockings application, hypertension, pulmonary embolism, varicose vein, venous thrombosis limb. TAREG dosage: unknown. During the same period patient was treated with IDARAC, PREVISCAN, ENDOTELON, OROCAL D, DIDRONEL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CHILE reported TAREG problem on Feb 15, 2007. Female patient was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: arrhythmia. TAREG dosage: unknown. During the same period patient was treated with DILATREND. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on Mar 14, 2007. Female patient, 79 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: arrhythmia. TAREG dosage: unknown. During the same period patient was treated with CARVEDILOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Mar 14, 2007. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, arthralgia, c-reactive protein increased, cytomegalovirus antibody positive, dermatitis psoriasiform, eczema, epstein-barr virus antigen positive, inflammation, parvovirus b19 serology positive. TAREG dosage: 160 MG/DAY. During the same period patient was treated with ATACAND, MICARDIS. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on Mar 19, 2007. Female patient, 86 years of age, weighting 88.18 lb, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: anaemia, fall, haemoglobin decreased, head injury, hiatus hernia, hyperhidrosis, hypotension, pain, pyrexia. TAREG dosage: 40 MG, QD. During the same period patient was treated with LERCAN, TOPALGIC, DOLIPRANE, LOVENOX, MEMANTINE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported TAREG problem on Mar 27, 2007. Female patient, 52 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, gamma-glutamyltransferase increased, livedo reticularis, lymphocytic infiltration, rash erythematous, red blood cell sedimentation rate increased. TAREG dosage: 80 MG, QD. During the same period patient was treated with METFORMIN. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Physician from ALGERIA on Apr 03, 2007. Female patient, 60 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: renal failure chronic. TAREG dosage: 80 MG, QD. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Apr 05, 2007. Female patient, 86 years of age, weighting 88.18 lb, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: anaemia, fall, haemoglobin decreased, head injury, hiatus hernia, hyperhidrosis, hypotension, pain, pyrexia. TAREG dosage: 40 MG, QD. During the same period patient was treated with LERCAN, TOPALGIC, DOLIPRANE, LOVENOX, MEMANTINE. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on Apr 10, 2007. Female patient, 62 years of age, was diagnosed with blood pressure increased and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. TAREG dosage: VALS 160 / HCT 12.5 MG/DAY. During the same period patient was treated with CIMAL, EUTIROX. Patient recovered.
Physician from FRANCE reported TAREG problem on Apr 16, 2007. Female patient, 75 years of age, weighting 136.7 lb, was diagnosed with hypertension, coronary artery disease and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: erythema multiforme. TAREG dosage: 80 MG, QD. During the same period patient was treated with ASPEGIC, CORVASAL, TAHOR, INEGY. Patient recovered.
TAREG problem was reported by a Physician from FRANCE on Apr 16, 2007. Female patient, 75 years of age, weighting 136.7 lb, was diagnosed with hypertension, coronary artery disease and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: erythema multiforme. TAREG dosage: 80 MG, QD. During the same period patient was treated with ASPEGIC, CORVASAL, TAHOR, INEGY. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Apr 18, 2007. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, arthralgia, c-reactive protein increased, cytomegalovirus antibody positive, dermatitis psoriasiform, eczema, epstein-barr virus antigen positive, inflammation, parvovirus b19 serology positive. TAREG dosage: 160 MG/DAY. During the same period patient was treated with ATACAND, MICARDIS. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on June 13, 2007. Female patient, 62 years of age, was diagnosed with blood pressure increased and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, gait disturbance. TAREG dosage: VALS 160 / HCT 12.5 MG/DAY. During the same period patient was treated with CIMAL, EUTIROX. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on June 14, 2007. Male patient, 37 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: azoospermia. TAREG dosage: 80 MG, QD. During the same period patient was treated with INDAPAMIDE, ASPIRIN. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on June 18, 2007. Female patient, 65 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac disorder, cardiac pacemaker insertion, fatigue. TAREG dosage: 80 MG, QD. During the same period patient was treated with ATORVASTATIN, WELLBUTRIN, RAVOTRIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CHILE reported TAREG problem on July 03, 2006. Male patient, 65 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: bundle branch block. TAREG dosage: VALS 160 MG/ HCT 12.5 MG/DAY. During the same period patient was treated with DILATREND, CEFALMIN. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on July 10, 2006. Female patient, 76 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, eosinophilia, erythema multiforme, rash maculo-papular, toxic skin eruption. TAREG dosage: unknown. During the same period patient was treated with DIAMICRON, LANTUS, LAMISIL, KERLONE, METFORMIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Physician from ALGERIA reported TAREG problem on July 18, 2006. Female patient, 45 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: cough, face oedema, respiratory disorder. TAREG dosage: unknown. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on July 03, 2006. Male patient, 65 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: sciatica, therapeutic procedure. TAREG dosage: VALS 160 MG/ HCT 12.5 MG/DAY. During the same period patient was treated with DILATREND, CEFALMIN. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Aug 01, 2006. Male patient, 55 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: cough, fatigue, ischaemia, productive cough. TAREG dosage: 80 MG, QD. During the same period patient was treated with STAGID, TRANDATE, ZOCOR, ESCITALOPRAM OXALATE, PLAVIX, ASPIRIN, NOVONORM. Patient died on 06/17/2006.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on Aug 07, 2006. Female patient, 96 years of age, weighting 81.57 lb, was diagnosed with hypertension, diabetes mellitus and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, cerebrovascular accident, creatinine renal clearance decreased, electrocardiogram abnormal, hyperkalaemia, renal failure. TAREG dosage: 160 MG/DAY. During the same period patient was treated with PNEUMOREL, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, LERCAN, DAONIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on July 10, 2006. Female patient, 76 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, dermatitis exfoliative, eosinophilia, erythema multiforme, neutropenia, pruritus, rash maculo-papular, toxic skin eruption. TAREG dosage: unknown. During the same period patient was treated with DIAMICRON, LANTUS, LAMISIL, KERLONE, METFORMIN, ASPIRIN. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on Aug 18, 2006. Female patient, 69 years of age, weighting 123.5 lb, was diagnosed with hypertension, back pain, colonoscopy and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: albuminuria, back pain, blood creatinine increased, creatinine renal clearance decreased, dehydration, diarrhoea, hypotension, hypovolaemia. TAREG dosage: 80 MG/DAY. During the same period patient was treated with NABUCOX, FORLAX, MEDIVEINE, TRAMADOL, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Physician from CHILE reported TAREG problem on Aug 24, 2006. Female patient was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, chest discomfort, chills, dyspnoea, malaise, pyrexia. TAREG dosage: VALS 160 / HCT 12.5 MG/DAY. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Female patient, 82 years of age, was diagnosed with hypertension, atrial flutter and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, blood creatinine increased, blood urea increased, creatinine renal clearance decreased, ear, nose and throat examination abnormal, glomerulonephritis, haematuria, hyperkalaemia, lung disorder. TAREG dosage: 80 MG/DAY. During the same period patient was treated with BACTRIM, LASILIX, PREVISCAN, TENORMIN, DIGOXIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Sept 05, 2006. Female patient, 82 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema. TAREG dosage: 80 MG DAILY. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from FRANCE on Sept 29, 2006. Female patient, 92 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: asthenia, blood potassium increased, creatinine renal clearance decreased, renal failure, therapeutic agent toxicity. TAREG dosage: unknown. During the same period patient was treated with DIGOXIN, LASIX, DIFFU K, LIPANOR. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported TAREG problem on Sept 22, 2006. Female patient, 37 years of age, weighting 154.3 lb, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: asthenia, discomfort, impaired driving ability, somnolence. TAREG dosage: 80 MG, QD. During the same period patient was treated with ADEPAL. Patient recovered.
TAREG problem was reported by a Physician from FRANCE on Oct 13, 2006. Female patient, 75 years of age, was diagnosed with myocardial infarction and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: erythema multiforme. TAREG dosage: 80 MG, QD. During the same period patient was treated with ASPEGIC, CORVASAL, TAHOR. Patient recovered.
Physician from ALGERIA reported TAREG problem on Oct 29, 2006. Female patient, 70 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, blood pressure immeasurable. TAREG dosage: unknown. Patient recovered.
TAREG problem was reported by a Physician from ITALY on Nov 03, 2006. Female patient, 57 years of age, was diagnosed with hypertension, headache and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: urticaria. TAREG dosage: 80 MG, UNK. During the same period patient was treated with MOMENT. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Nov 07, 2006. Female patient, 67 years of age, weighting 158.7 lb, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, creatinine renal clearance decreased, dehydration, dizziness postural, nausea, orthostatic hypotension. TAREG dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on Nov 29, 2006. Male patient, 82 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: cardiac failure. TAREG dosage: 80/12.5 MG/DAY. Patient died on 02/01/2005.
Consumer or non-health professional from FRANCE reported TAREG problem on Nov 24, 2006. Female patient, 72 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, eosinophilia, gamma-glutamyltransferase increased, pyrexia, rash, rash erythematous. TAREG dosage: unknown. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on Dec 11, 2006. Male patient, 65 years of age, weighting 229.3 lb, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: arrhythmia, chest discomfort, ejection fraction decreased, electrocardiogram abnormal, fatigue, myocardial infarction, ventricular hypertrophy. TAREG dosage: 160 MG/DAY. During the same period patient was treated with ISOSORBIDE, NEO SINTROM, CARVEDILOL, ASPIRIN, FUROSEMIDE, ESPIRONOLACTONA. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported TAREG problem on Dec 19, 2006. Female patient, 73 years of age, was diagnosed with hypertension, breast cancer and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, scotoma. TAREG dosage: 80 MG, QD. During the same period patient was treated with FEMARA. Patient recovered.
TAREG problem was reported by a Health Professional from FRANCE on July 11, 2007. Female patient, 39 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: oliguria. TAREG dosage: 80 MG/DAY. Patient recovered.
Physician from SOUTH AFRICA reported TAREG problem on July 18, 2007. Male patient, 58 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: pneumonia. TAREG dosage: 160 MG/DAY. During the same period patient was treated with ZETOMAX. Patient recovered.
TAREG problem was reported by a Health Professional from FRANCE on July 31, 2007. Female patient, 39 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: accidental exposure, blood uric acid, caesarean section, foetal disorder, foetal heart rate abnormal, oligohydramnios, oliguria, pre-eclampsia. TAREG dosage: 80 MG/DAY. During the same period patient was treated with LOXEN, TRANDATE, ALDOMET. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported TAREG problem on July 31, 2007. Male patient, weighting 4.21 lb, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia neonatal, premature baby. TAREG dosage: unknown. During the same period patient was treated with LOXEN, TRANDATE, ALDOMET. Patient recovered.
TAREG problem was reported by a Physician from SOUTH AFRICA on Aug 06, 2007. Male patient, 60 years of age, weighting 222.7 lb, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: bronchitis, cough, pneumonia. TAREG dosage: 160 MG/DAY. During the same period patient was treated with ZETOMAX, DIOVAN. Patient recovered.
Health Professional from FRANCE reported TAREG problem on Aug 09, 2007. Male patient was diagnosed with hypertension, hyperkalaemia and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: confusional state, hypokalaemia. TAREG dosage: unknown. During the same period patient was treated with LASIX, KAYEXALATE. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Aug 20, 2007. Female patient, 68 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, limb discomfort, pain in extremity. TAREG dosage: 80 MG, QD. During the same period patient was treated with VITAMIN, CALCIUM, FISH OIL. Patient recovered.
Consumer or non-health professional from FRANCE reported TAREG problem on Aug 20, 2007. Male patient, 79 years of age, was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: asthenia, blood creatinine increased, blood urea increased, bradycardia, chest pain, fibrin d dimer increased, haemodialysis, hyperkalaemia, polyuria. TAREG dosage: 160 MG, QD. During the same period patient was treated with ALDALIX, CELECTOL, PRAVASTATIN, RENITEC, GLUCOPHAGE, ALLOPURINOL, LANTUS. Patient was hospitalized. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on Aug 28, 2007. Female patient, 65 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac arrest, cardiac disorder, cardiac pacemaker insertion, fatigue. TAREG dosage: 80 MG, QD. During the same period patient was treated with ATORVASTATIN, WELLBUTRIN, RAVOTRIL, SERTRALINE, CARDIOASPIRINA. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CHILE reported TAREG problem on Aug 28, 2007. Male patient, 43 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: angina unstable. TAREG dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Sept 03, 2007. Female patient, 68 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, limb discomfort, pain in extremity. TAREG dosage: 80 MG, QD. During the same period patient was treated with VITAMINS, CALCIUM, FISH OIL. Patient recovered.
Consumer or non-health professional from SOUTH AFRICA reported TAREG problem on Sept 07, 2007. Female patient, 68 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, limb discomfort, pain in extremity. TAREG dosage: 80 MG, QD. During the same period patient was treated with VITAMINS, CALCIUM, FISH OIL. Patient recovered.
TAREG problem was reported by a Consumer or non-health professional from CHILE on Sept 12, 2007. Female patient, 55 years of age, was diagnosed with hypertension and was treated with TAREG. After drug was administered, patient experienced the following problems/side effects: thyroid cancer, thyroid operation. TAREG dosage: 160 MG, QD. During the same period patient was treated with CARVEDILOL, AMLODIPINE, CEFALMIN. Patient was hospitalized. Patient recovered.